Source comparison
Direct NAD+ Precursors: NR vs NMN for Athletic Application
The two primary NAD+ precursors used in endurance athletes NAD+ protocol design are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both bypass the rate-limiting step of the salvage pathway. The enzyme NAMPT, which converts nicotinamide back
This comparison does not assign a generated winner or score.
- The two primary NAD+ precursors used in endurance athletes NAD+ protocol design are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both bypass the rate-limiting step of the salvage pathway. The enzyme NAMPT, which converts nicotinamide back to NAD+ and becomes saturated during high metabolic demand. NR is phosphorylated to NMN inside cells, then converted to NAD+. NMN is one enzymatic step closer to NAD+ and may have faster tissue uptake in skeletal muscle, though clinical evidence remains mixed on whether this translates to superior performance outcomes.
- A 2021 randomised controlled trial published in Science compared 1000mg NMN daily vs placebo in recreationally active adults over 10 weeks. The NMN group showed 11.3% improvement in aerobic capacity (measured as VO2 max during incremental treadmill test) and significantly higher blood NAD+ levels post-supplementation. Muscle biopsy data revealed increased mitochondrial enzyme activity. Specifically, elevated expression of PGC-1α, the master regulator of mitochondrial biogenesis. NR has similar evidence: a 2019 study in Nature Communications found that 1000mg NR twice daily for 21 days increased skeletal muscle NAD+ by 60% and improved markers of mitochondrial function in middle-aged adults.
- The practical difference for athletes: NMN may raise blood NAD+ levels faster due to direct cellular uptake via the Slc12a8 transporter identified in 2019, whereas NR must enter cells and undergo phosphorylation first. For pre-training loading or acute replenishment windows, NMN's faster kinetics could matter. For daily baseline maintenance, both precursors produce comparable steady-state NAD+ elevation when dosed consistently. Cost and availability often dictate choice. NR has broader third-party testing and longer supplement market presence; NMN research is newer but growing rapidly. Real Peptides focuses on research-grade compounds synthesised under controlled conditions. Purity and exact amino-acid sequencing matter when you're targeting specific metabolic pathways.